Holen Sie sich die Stockscreener-App
24.33
3.09%
0.73
Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten
Is Catalyst Pharmaceuticals Inc.’s growth already priced inJuly 2025 Highlights & Long-Term Capital Growth Strategies - mfd.ru
Block Trades: Is iShares Gold Trust impacted by rising ratesInflation Watch & Community Consensus Trade Alerts - baoquankhu1.vn
What is Catalyst Pharmaceuticals Inc. s 5 year growth outlookWeekly Trade Summary & AI Enhanced Trading Alerts - mfd.ru
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - GlobeNewswire
Catalyst Pharmaceuticals (CPRX) Investor Outlook: A Promising 41.4% Upside Potential - DirectorsTalk Interviews
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Renewed Interest And Pocket Pivot Signal - Sahm
Allianz Asset Management GmbH Cuts Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Growth with Bullish Technical Setup - ChartMill
Catalyst Pharmaceuticals (NASDAQ:CPRX) shareholders have earned a 41% CAGR over the last five years - Yahoo Finance
What is the next catalyst for Oramed Pharmaceuticals Inc.July 2025 Sentiment & Stock Portfolio Risk Control - Mfd.ru
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance
Catalyst Pharmaceuticals, Inc. $CPRX Shares Acquired by Federated Hermes Inc. - MarketBeat
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Growth Strength And Positive Analyst Sentiment - Sahm
Aug Reactions: Is EDHL subject to activist investor interest2025 Volume Leaders & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Does Strong Financials And Rare-Disease Partnerships Change The Bull Case For Catalyst Pharmaceuticals (CPRX)? - Sahm
Ruffer LLP Makes New Investment in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Screens as an Affordable Growth Stock - Chartmill
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term - sharewise.com
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring A 45% Upside Potential - DirectorsTalk Interviews
Catalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Y Intercept Hong Kong Ltd - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 - The Motley Fool
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Fresh Rare Disease Momentum And Earnings Outperformance - Sahm
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Presents a Compelling Value Investment Case - Chartmill
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A 53.56% Potential Upside Beckons Investors - DirectorsTalk Interviews
Catalyst Pharmaceuticals, Inc. (CPRX): A Bull Case Theory - Insider Monkey
Campbell & CO Investment Adviser LLC Has $1.93 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
How Investors May Respond To Catalyst Pharmaceuticals (CPRX) Rare-Disease Strength And Potential Technical Breakout - Sahm
Jim Cramer on Catalyst Pharmaceuticals: “It’s a Very Inexpensive Stock” - Insider Monkey
First Week of September 18th Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
SG Americas Securities LLC Raises Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Fundamentals with a Technical Breakout Setup - Chartmill
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - sharewise.com
Short Squeeze: What is the next catalyst for Actinium Pharmaceuticals IncProfit Target & Technical Confirmation Trade Alerts - baoquankhu1.vn
Bank Watch: Is Catalyst Pharmaceuticals Inc. stock influenced by commodity pricesJuly 2025 Review & Weekly Momentum Picks - baoquankhu1.vn
Catalyst Pharmaceuticals (CPRX) Stock Analysis: A 50% Upside Potential in the Biotech Arena - DirectorsTalk Interviews
Catalyst Pharmaceuticals, Inc. Presents at JP Morgan Healthcare Conference - TradingView
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Forbes 2026 Small Cap Recognition - Sahm
Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today - MSN
Will Catalyst Pharmaceuticals Inc. stock see insider buyingQuarterly Trade Summary & Daily Stock Trend Reports - ulpravda.ru
How Catalyst Pharmaceuticals Inc. stock benefits from tech adoption2025 Trading Recap & Fast Momentum Stock Entry Tips - ulpravda.ru
Does Forbes’ Small-Cap Honor for Sales Growth Reshape the Bull Case For Catalyst Pharmaceuticals (CPRX)? - Yahoo Finance
Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? - Yahoo Finance
How Forbes’ Small-Cap Accolade Will Impact Catalyst Pharmaceuticals (CPRX) Investors - Sahm
Will Catalyst Pharmaceuticals Inc. stock benefit from green energy trendsEntry Point & Consistent Profit Trading Strategies - Улправда
Catalyst Pharmaceuticals Executive Cashes Out 10,983 Shares -- What's Behind the Move? - AOL.com
How Catalyst Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Exit Report & Verified Chart Pattern Trade Signals - ulpravda.ru
Funds from operations of Catalyst Pharmaceuticals, Inc. – FWB:CN2 - TradingView — Track All Markets
Is Catalyst Pharmaceuticals Inc. stock a buy before product launchesJuly 2025 Market Mood & Real-Time Market Trend Scan - ulpravda.ru
Will Catalyst Pharmaceuticals Inc. stock maintain dividend yield2025 Geopolitical Influence & Free Community Consensus Stock Picks - Улправда
Santhera Seals APAC Pact For Agamree - Citeline News & Insights
Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now? - Yahoo Finance
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies - The Manila Times
Catalyst Pharmaceuticals Receives Prestigious Ranking on - GlobeNewswire
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Prospects Need A Boost To Lift Shares - 富途牛牛
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):